Molecular Imaging gets off to good revenue start in FY04

Mobile positron emission tomography (PET) supplier Molecular Imaging Corp. has released its unaudited results for its first fiscal quarter of 2004, ending Sept. 30. Revenues increased to $5.6 million, up 13 percent from $4.6 million in the first quarter of FY03. Gross profit rose to $2.1 million, compared with $1.5 million in the year-ago quarter.

 Molecular Imaging credited a 24 percent decline in selling and marketing expenses for its heightened profit. For the quarter, the company also reported a loss of $408,049 from continuing operations, compared to losses from continuing operations of $821,974 in the year-ago quarter.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup